Status:
NOT_YET_RECRUITING
The Effects of the Otago Exercise Program
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Pulmonary Arterial Hypertension
Heart Defects, Congenital
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this experimental study is to conduct a comparative evaluation of the effects of a supervised Otago Exercise Program (OEP) functional exercise capacity, blood lactate levels, dyspnea,...
Detailed Description
Pulmonary hypertension (PH) is characterized by a mean pulmonary artery pressure exceeding 20 mmHg, as measured during heart catheterization. In patients with PH, a pulmonary artery wedge pressure of ...
Eligibility Criteria
Inclusion
- Being clinically and hemodynamically stable.
- Resting mean pulmonary artery pressure measured with left heart catheterization to be 20 mmHg or higher.
- Being 18 years of age or older.
- Being classified as World Health Organization-functional class II and III.
- Being under optimized advanced medical treatment for PAH for at least 2 months before entering the study.
- No changes in pulmonary arterial hypertension medical treatment for at least 6 months before entering the study.
Exclusion
- The coexistence of Down syndrome.
- Group 1 PAH patients with another etiology.
- Changes in PAH medical treatment during follow-up.
- Acute decompensated heart failure.
- Unstable angina pectoris.
- Recent thoracic or abdominal surgeries.
- Using immunosuppressive drugs due to organ or tissue transplantation.
- Heavy neurological disorders causing autonomic dysfunction.
- The presence of cognitive impairment preventing communication.
- Recent syncope, fractures, osteoporosis, presence of tumors, pregnancy.
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06172790
Start Date
February 1 2024
End Date
February 1 2026
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University - Cerrahpasa (IUC) Cardiology Institute
Istanbul, Fatih, Turkey (Türkiye)